Cell Death and Disease (Jan 2024)

GRB2 is a BECN1 interacting protein that regulates autophagy

  • Jetsy Montero-Vergara,
  • Kira Plachetta,
  • Lisa Kinch,
  • Stephan Bernhardt,
  • Kriti Kashyap,
  • Beth Levine,
  • Lipi Thukral,
  • Martina Vetter,
  • Christoph Thomssen,
  • Stefan Wiemann,
  • Samuel Peña-Llopis,
  • Verena Jendrossek,
  • Silvia Vega-Rubin-de-Celis

DOI
https://doi.org/10.1038/s41419-023-06387-7
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 11

Abstract

Read online

Abstract GRB2 is an adaptor protein of HER2 (and several other tyrosine kinases), which we identified as a novel BECN1 (Beclin 1) interacting partner. GRB2 co-immunoprecipitated with BECN1 in several breast cancer cell lines and regulates autophagy through a mechanism involving the modulation of the class III PI3Kinase VPS34 activity. In ovo studies in a CAM (Chicken Chorioallantoic Membrane) model indicated that GRB2 knockdown, as well as overexpression of GRB2 loss-of-function mutants (Y52A and S86A-R88A) compromised tumor growth. These differences in tumor growth correlated with differential autophagy activity, indicating that autophagy effects might be related to the effects on tumorigenesis. Our data highlight a novel function of GRB2 as a BECN1 binding protein and a regulator of autophagy.